NM_000551.4:c.593T>C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000551.4(VHL):c.593T>C(p.Leu198Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L198Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000551.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VHL | NM_000551.4 | c.593T>C | p.Leu198Pro | missense_variant | Exon 3 of 3 | ENST00000256474.3 | NP_000542.1 | |
VHL | NM_198156.3 | c.470T>C | p.Leu157Pro | missense_variant | Exon 2 of 2 | NP_937799.1 | ||
VHL | NM_001354723.2 | c.*147T>C | 3_prime_UTR_variant | Exon 3 of 3 | NP_001341652.1 | |||
VHL | NR_176335.1 | n.922T>C | non_coding_transcript_exon_variant | Exon 4 of 4 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Von Hippel-Lindau syndrome Pathogenic:2Uncertain:1
- -
- -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.L198P variant (also known as c.593T>C), located in coding exon 3 of the VHL gene, results from a T to C substitution at nucleotide position 593. The leucine at codon 198 is replaced by proline, an amino acid with similar properties. This variant has been reported as de novo in a Swedish patient meeting clinical diagnostic criteria for von Hippel-Lindau syndrome (VHL): he was diagnosed with a pancreatic neuroendocrine tumor at age 15y and a retinal hemangioblastoma and bilateral pheochromocytomas at age 16y (Wittstrom E et al. Ophthalmic Genet. 2014 Jun;35(2):91-106). This variant has also been detected in a patient with a personal and family history of bilateral pheochromocytomas (Lomte N et al. Fam Cancer. 2018 Jul;17(3):441-449). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Ambry internal data). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at